Presentation is loading. Please wait.

Presentation is loading. Please wait.

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study 

Similar presentations


Presentation on theme: "VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study "— Presentation transcript:

1 VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study  Julie E. Chang, Lakeesha L. Carmichael, KyungMann Kim, Christopher Peterson, David T. Yang, Anne M. Traynor, Jae E. Werndli, Michael S. Huie, Thomas A. McFarland, Michael Volk, Jules Blank, Natalie S. Callander, Walter L. Longo, Brad S. Kahl  Clinical Lymphoma, Myeloma and Leukemia  Volume 18, Issue 1, Pages e61-e67 (January 2018) DOI: /j.clml Copyright © 2017 Elsevier Inc. Terms and Conditions

2 Figure 1 Progression-free Survival. The Single Event at 8 Years was Death From Lung Cancer (Mantle Cell Lymphoma in Ongoing Remission) Clinical Lymphoma, Myeloma and Leukemia  , e61-e67DOI: ( /j.clml ) Copyright © 2017 Elsevier Inc. Terms and Conditions


Download ppt "VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study "

Similar presentations


Ads by Google